Patterns of Care for Adjuvant Therapy in a Random Population-Based Sample of Patients Diagnosed with Colorectal Cancer
Authors:
- 1 October 2006
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 101 (10) , 2308-2318
Abstract
Over the past decade, clinical trials have proved the efficacy of treatments for colorectal cancer (CRC). This study tracks dissemination of these treatments for patients diagnosed with stage II and III disease and compares risk of death for those who received guideline therapy to those who did not. We conducted a stratified randomly sampled, population-based study of CRC treatment trends in the United States. Multivariate models were used to explore patient characteristics associated with receipt of treatments. We pooled data with a previous study—patients diagnosed in 1987–1991 and 1995. Cox proportional hazards models were used to assess observed cause-specific and all-cause mortality. In 2000, guideline therapy receipt decreased among stage III rectal cancer patients, but increased for stage III colon and stage II rectal cancer patients. As age increased, likelihood of receiving guideline treatment decreased (p < 0.0001). Overall, race/ethnicity was significantly associated with guideline therapy (p = 0.04). Rectal patients were less likely to have received guideline treatment. Consistent with randomized clinical trial findings, all-cause mortality was lower in patients who received guideline therapy, regardless of Charlson comorbidity score. Mortality was decreased in patients receiving guideline therapy. Although, rates of guideline-concordant therapy are low in community clinical practice, they are apparently increasing. Newer treatment (oxaliplatin, capecitabine) started to disseminate in 2000. Racial disparities, present in 1995, were not detected in 2000. Age disparities remain despite no evidence of greater chemotherapy-induced toxicity in the elderly. More equitable receipt of cancer treatment to all segments of the community will help to reduce mortality.Keywords
This publication has 41 references indexed in Scilit:
- Patterns of Presentation, Diagnosis, and Treatment in Older Patients with Colon Cancer and Comorbid DementiaJournal of the American Geriatrics Society, 2004
- Racial and Ethnic Disparities in the Receipt of Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2002
- Age, Sex, and Racial Differences in the Use of Standard Adjuvant Therapy for Colorectal CancerJournal of Clinical Oncology, 2002
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancerDiseases of the Colon & Rectum, 1999
- Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west NetherlandsEuropean Journal of Surgical Oncology, 1998
- Age and Clinical Decision Making in Oncology PatientsJNCI: Journal of the National Cancer Institute, 1994
- Cancer Treatment and Age: Patient PerspectivesJNCI: Journal of the National Cancer Institute, 1993
- NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancerJAMA, 1990
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987